share_log

OneMedNet Network Expands With New Partnership With Large Academic Research Medical Center to Benefit Its Life Science Company Clients

OneMedNet Network Expands With New Partnership With Large Academic Research Medical Center to Benefit Its Life Science Company Clients

OneMedNet Network 與大型學術研究醫療中心建立了新的合作伙伴關係,以使其生命科學公司的客戶受益
Accesswire ·  2023/11/10 05:15

~ Partnership To Leverage Real World Data for Life Science Innovation Accelerating New Diagnostic and Treatment Solutions ~

~ 合作利用現實世界的數據進行生命科學創新,加速新的診斷和治療解決方案 ~

MINNEAPOLIS, MN / ACCESSWIRE / November 9, 2023 / OneMedNet Corporation (Nasdaq:ONMD) ("OneMedNet"), the leading curator of regulatory-grade imaging Real World Data ("RWD"), today announced a new partnership with a leading research medical center to accelerate and expand development of new diagnostic and treatment solutions using OneMedNet's iRWD. Life Science innovators, including pharmaceutical, AI, medical device, and clinical research organizations, are now able to effectively use existing real world data for discovery, development, regulatory-approval, and post-market surveillance.

明尼蘇達州明尼阿波利斯/ACCESSWIRE /2023 年 11 監管級成像真實世界數據(“RWD”)的領先策展人OnemedNet Corporation(納斯達克股票代碼:onMD)(“OnemedNet”)今天宣佈與一家領先的研究醫學中心建立新的合作伙伴關係,以加速和擴大使用OnemedNet的iRWD的新診斷和治療解決方案的開發。生命科學創新者,包括製藥、人工智能、醫療設備和臨床研究組織,現在能夠有效地使用現有的現實世界數據進行發現、開發、監管批准和上市後監測。

"This is great news for OneMedNet who is committed to providing our Life Science company clients with access to the critical RWD they need to succeed. The challenge for Life Science companies is not the utilization of RWD in their processes, but obtaining the highly specific data that unequivocally meets all of their required data attributes," said Aaron Green, OneMedNet President. "We've been safely and securely identifying, indexing and de-identifying imaging data for well over a decade. OneMedNet's leadership in providing the most current regulatory grade data has proven invaluable to both healthcare providers and Life Sciences."

“對於致力於爲我們的生命科學公司的客戶提供獲得成功所需的關鍵 RWD 的途徑的 OneMedNet 來說,這是個好消息。OneMedNet總裁亞倫·格林說,生命科學公司面臨的挑戰不是在流程中使用RWD,而是獲得明確符合其所有必要數據屬性的高度具體的數據。“十多年來,我們一直在安全地識別、索引和取消識別成像數據。事實證明,OneMedNet在提供最新監管等級數據方面的領導地位對醫療保健提供商和生命科學都非常寶貴。”

This essential data which fuels technology and clinical advancement can sit idle and unproductive without healthcare providers engagement. Importantly, academic tertiary centers also offer significant data diversity which is a high priority for the Food and Drug Administration when reviewing regulatory submissions.

如果沒有醫療保健提供者的參與,這些推動技術和臨床進步的基本數據可能會處於閒置狀態,生產力低下。重要的是,高等教育中心還提供了顯著的數據多樣性,這是美國食品藥品監督管理局在審查監管申報時的重中之重。

The OneMedNet iRWD network consists of over 200 healthcare systems and providers. The addition of this tertiary medical center expands OneMedNet's carefully compiled RWD to 20 research centers and institutions. The main hospital is ranked in the top 40 nationwide and features one of the leading cancer centers. Given that oncology RWD is of highest demand, this represents a significant OneMedNet network addition.

OneMedNet iRWD 網絡由 200 多個醫療保健系統和提供商組成。這個三級醫療中心的加入將OneMedNet精心編制的RWD擴展到20個研究中心和機構。該主要醫院位列全國前40名,擁有領先的癌症中心之一。鑑於腫瘤學 RWD 的需求最高,這意味着 OneMedNet 網絡的顯著增加。

About OneMedNet Corporation

關於 OnemedNet 公司

Founded in 2009, OneMedNet provides innovative solutions that unlock the significant value contained within the clinical image archives of healthcare providers. Employing its proven OneMedNet iRWD solution, OneMedNet securely de-identifies, searches, and curates a data archive locally, bringing a wealth of internal and third-party research opportunities to providers. By leveraging this extensive federated provider network, together with industry leading technology and in-house clinical expertise, OneMedNet successfully meets the most rigorous RWD Life Science requirements. For more information, please visit .

OneMedNet成立於2009年,提供創新的解決方案,釋放醫療保健提供者臨床圖像檔案中包含的巨大價值。OneMedNet 採用其久經考驗的 OneMedNet iRWD 解決方案,可在本地安全地進行去身份識別、搜索和整理數據檔案,爲提供商帶來豐富的內部和第三方研究機會。通過利用這個廣泛的聯合提供商網絡,以及行業領先的技術和內部臨床專業知識,OneMedNet成功地滿足了最嚴格的 RWD 生命科學要求。欲了解更多信息,請訪問。

Investor Contact:

投資者聯繫人:

Shannon Devine
MZ Group North America
203-741-8811
ONMD@mzgroup.us

香農迪瓦恩
MZ 集團北美
203-741-8811
ONMD@mzgroup.us

SOURCE: OneMedNet

來源: OneMedNet


View source version on accesswire.com:
在 accesswire.com 上查看源代碼版本:

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論